Early Gray Matter Volume Loss in MAPT H1H1 de Novo PD Patients: A Possible Association With Cognitive Decline

The MAPT H1 haplotype has been identified as a predictor of cognitive decline in Parkinson's disease (PD). However, its underlying pathological mechanisms have not been fully established. In this work, using a cohort of 120 de novo PD patients with preserved cognition from the Parkinson's...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Neurology
المؤلفون الرئيسيون:	Frederic Sampedro, Juan Marín-Lahoz, Saul Martínez-Horta, Javier Pagonabarraga, Jaime Kulisevsky
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2018-05-01
الموضوعات:	MAPT T1-MRI cognitive decline Parkinson's disease gray matter volume
الوصول للمادة أونلاين:	https://www.frontiersin.org/article/10.3389/fneur.2018.00394/full

مواد مشابهة

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
حسب: Juan Marín-Lahoz, وآخرون
منشور في: (2018-09-01)

Fatigue and neuropsychiatric symptoms in Parkinson’s disease: a narrative review
حسب: Lidia Bojtos, وآخرون
منشور في: (2025-10-01)

The Free and Cued Selective Reminding Test in Parkinson's Disease Mild Cognitive Impairment: Discriminative Accuracy and Neural Correlates
حسب: Andrea Horta-Barba, وآخرون
منشور في: (2020-04-01)

CSF Biomarker‐Based Cognitive Trajectories in Parkinson's Disease‐Subjective Cognitive Decline
حسب: Jon Rodriguez‐Antiguedad, وآخرون
منشور في: (2025-08-01)

Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
حسب: Iñigo Ruiz-Barrio, وآخرون
منشور في: (2022-04-01)

Approaches for treating neuropsychiatric symptoms in Parkinson’s disease: a narrative review
حسب: Jon Rodríguez-Antigüedad, وآخرون
منشور في: (2025-05-01)

Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities
حسب: Irene Berzosa-Gonzalez, وآخرون
منشور في: (2024-12-01)

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification
حسب: Alexandre Gironell, وآخرون
منشور في: (2018-01-01)

Cognitive phenotype and neurodegeneration associated with Tau in Huntington's disease
حسب: Saul Martinez‐Horta, وآخرون
منشور في: (2024-05-01)

Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study
حسب: Saul Martinez-Horta, وآخرون
منشور في: (2021-10-01)

Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
حسب: Arnau Puig‐Davi, وآخرون
منشور في: (2025-06-01)

Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers
حسب: Yiyuan Pan, وآخرون
منشور في: (2018-02-01)

21450. DESARROLLO Y VALIDACIÓN DE UNA ESCALA MULTIDIMENSIONAL PARA EL DIAGNÓSTICO DIFERENCIAL DE PARKINSONISMOS ATÍPICOS
حسب: Í. Ruiz Barrio, وآخرون
منشور في: (2024-11-01)

Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease
حسب: Frederic Sampedro, وآخرون
منشور في: (2021-12-01)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
حسب: Pascual Sánchez-Juan, وآخرون
منشور في: (2019-12-01)

20836. ESTUDIO DE LAS MANIFESTACIONES LINGÜÍSTICAS Y DEL HABLA EN LA ATROFIA MULTISISTÉMICA
حسب: A. Horta Barba, وآخرون
منشور في: (2024-11-01)

Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
حسب: Mercè Martínez-Corral, وآخرون
منشور في: (2010-01-01)

A MAPT mutation in a regulatory element upstream of exon 10 causes frontotemporal dementia
حسب: Roneil Malkani, وآخرون
منشور في: (2006-05-01)

21518. ABORDAJE TERAPÉUTICO DE LOS TRASTORNOS POR TICS PRIMARIOS Y COMORBILIDADES PSIQUIÁTRICAS ASOCIADAS
حسب: I. Berzosa González, وآخرون
منشور في: (2024-11-01)

Rates of lobar atrophy in asymptomatic MAPT mutation carriers
حسب: Qin Chen, وآخرون
منشور في: (2019-01-01)

Blood MAPT expression and methylation status in Alzheimer's disease
حسب: Hiroaki Mori, وآخرون
منشور في: (2022-12-01)

Evaluación de la satisfacción médico/paciente con el uso del “Parkinson's Disease Dementia-Short-Screen” (PDD-SS): un test de cribado para la demencia en la enfermedad de Parkinson (estudio DIFUSION)
حسب: J. Kulisevsky, وآخرون
منشور في: (2011-10-01)

Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study)
حسب: J. Kulisevsky, وآخرون
منشور في: (2011-10-01)

A comprehensive analysis of MAPT-related genetic risk in Alzheimer’s disease
حسب: Shitao Wang, وآخرون
منشور في: (2025-06-01)

<i>MAPT</i> Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes
حسب: Monica Gagliardi, وآخرون
منشور في: (2025-06-01)

Tau (MAPT) haplotypes in Jordan: new evidence on the Middle East as a melting-pot predating Neolithic migration
حسب: Almuthanna K. Alkaraki, وآخرون
منشور في: (2021-07-01)

Editorial: New insights into the molecular basis of long-term plasticity underlying addiction and addictive behaviors
حسب: Juan Marín-Lahoz, وآخرون
منشور في: (2023-06-01)

Differential methylation of SNCA and MAPT genes associated with Parkinson’s disease in Mexican Mestizos
حسب: Ernesto G. Miranda-Morales, وآخرون
منشور في: (2025-07-01)

Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
حسب: Rosemary J. Jackson, وآخرون
منشور في: (2024-08-01)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. <i>Brain Sci.</i> 2020, <i>10</i>, 176
حسب: Javier Pagonabarraga, وآخرون
منشور في: (2020-05-01)

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
حسب: Javier Pagonabarraga, وآخرون
منشور في: (2020-03-01)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
حسب: Christina V. Tauber, وآخرون
منشور في: (2023-03-01)

An autopsied FTDP-17 case with MAPT IVS 10 + 14C > T mutation presenting with frontotemporal dementia
حسب: Ryohei Watanabe, وآخرون
منشور في: (2021-09-01)

Regulatory roles of eugenol in paraquat-altered SNCA/LZTS3/MAPT in the cerebellum of Wistar rats
حسب: Obinna Onwe Uchewa, وآخرون
منشور في: (2025-01-01)

20993. ESTUDIO LONGITUDINAL A UN AÑO DE LOS NIVELES DE NEUROFILAMENTO EN LCR Y PLASMA EN LA ENFERMEDAD DE HUNTINGTON
حسب: J. Pérez Pérez, وآخرون
منشور في: (2024-11-01)

Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of MAPT Mutations: A Systematic Review
حسب: Cristina Villa, وآخرون
منشور في: (2024-01-01)

Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism
حسب: Tyrique Richardson, وآخرون
منشور في: (2025-02-01)

What’s in a Gene? The Outstanding Diversity of <i>MAPT</i>
حسب: Daniel Ruiz-Gabarre, وآخرون
منشور في: (2022-03-01)

Functional MAPT haplotypes: Bridging the gap between genotype and neuropathology
حسب: Tara M. Caffrey, وآخرون
منشور في: (2007-07-01)

MAPT Mutations V337M and N297K Alter Organelle Trafficking in Frontotemporal Dementia Patient-Specific Motor Neurons
حسب: Christiane Hartmann, وآخرون
منشور في: (2024-03-01)